Clinicopathological characteristics | RFS | OS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Tumor location | ||||||
 Upper thoracic | 2.598 | 1.447–4.668 | 0.001 | 2.419 | 1.292–4.530 | 0.006 |
 Middle thoracic | 1 |  |  | 1 |  |  |
 Lower thoracic | 1.305 | 0.617–2.759 | 0.486 | 1.196 | 0.537–2.663 | 0.661 |
E-VI b | ||||||
 Positive | 2.402 | 1.160–4.974 | 0.018 | 2.908 | 1.288–6.568 | 0.010 |
 Negative | 1 |  |  | 1 |  |  |
CD31-VI c | ||||||
 Positive | 2.832 | 1.594–5.034 |  < 0.001 | - | - | - |
 Negative | 1 |  |  | - | - | - |
D2-40-LI d | ||||||
 L0 | 1 |  |  | - | - | - |
 L1 | 1.327 | 0.737–2.389 | 0.345 | - | - | - |
 L2 | 4.609 | 2.273–9.344 |  < 0.001 | - | - | - |
LNM e | ||||||
 Yes | - | - | - | 1.983 | 1.096–3.587 | 0.024 |
 No | - | - | - | 1 |  |  |